Study to Assess the Efficacy, Safety, and Tolerability of ADL5747 in Participants With Postherpetic Neuralgia

Conditions

• Postherpetic Neuralgia

Interventions

• DRUG: ADL5747
• DRUG: Placebo
• DRUG: Pregabalin

Sponsor

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Collaborators

• [object Object]